Comments
Loading...

Entero Therapeutics

ENTONASDAQ
Logo brought to you by Benzinga Data
$0.489800
-0.05-9.30%
At close: -
$0.489300
-0.0005-0.10%
After Hours: 5:14 PM EDT
Q3 2024 Earnings were released on Wed Nov 13th, before the market open
Journey Therapeutics, Inc announced it will be merged with Entero Therapeutics (ENTO) on Wednesday, November 13, 2024

Entero Therapeutics (NASDAQ:ENTO) Stock, Insider Trading Activity

Entero Therapeutics: Insider buying and selling updated today.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Entero Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

  • On October 10, 2024, Sarah Romano, the company's CHIEF FINANCIAL OFFICER sold 476 shares for $0.45 each.

Ownership Statistics for Entero Therapeutics Inc

Shares Outstanding
4.754M
Insider Shares Owned
757.774K
Insider Percentage Owned
15.9%
Institutional Shares Held
26.552K
Institutional Percentage Held
0.56%
Data brought to you by Benzinga APIs

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

ENTO Insider Trading News

No news found

People Also Watch